Authors | Population | Frequency of 16p11.2 deletion | Percent | Sum | Frequency of 16p11.2 duplication | Percent | Sum |
---|---|---|---|---|---|---|---|
ASD Cohorts | |||||||
Sebat et al. (2007)a | Sporadic ASD | 1/118 | 0.85% | 0.51% | 0/118 | 0.00% | 0.00% |
47 multiplex ASD families | 0/77 | 0.00% | Â | 0/77 | 0.00% | Â | |
Kumar et al. (2008) | Sporadic autism | 0/87 | 0.00% | 0.56% | 1/712 | 0.14% | 0.14% |
625 multiplex autism families | 4/625b | 0.64% | Â | Â | Â | Â | |
Weiss et al. (2008) | 751 multiplex autism families | 5/1441b | 0.35% | 0.46% | 7/1441 | 0.49% | 0.40% |
Icelandic patients with ASD | 3/299 | 1.00% | Â | 0/299 | 0.00% | Â | |
Christian et al. (2008)c | Sporadic ASD | 0/35 | 0.00% | 1.01% | Â | Â | Â |
362 multiplex ASD families | 4/362b | 1.10% | Â | Â | Â | Â | |
Marshall et al. (2008) | Sporadic ASD | 1/238 | 0.42% | 0.47% | 1/238 | 0.42% | 0.47% |
189 multiplex ASD families | 1/189 | 0.53% | Â | 1/189 | 0.53% | Â | |
Glessner et al. (2009)d | Sporadic & familial autism | 3/859 | 0.35% | 0.36% | 2/859 | 0.23% | 0.41% |
Sporadic & familial ASD | 5/1336b | 0.37% | Â | 7/1336 | 0.52% | Â | |
Other cohorts | |||||||
This study | Patients referred for clinical aCGH testing with ASD indication | 6/820 | 0.73% | 0.46% | 3/820 | 0.37% | 0.33% |
Patients referred for clinical aCGH testing without ASD indication | 39/8953 | 0.44% | Â | 29/8953 | 0.32% | Â | |
Rosenberg et al .(2006) | Patients with mental retardation, dysmorphic features, and normal karyotype | 1/81 | 1.23% | 1.23% | 0/81 | 0.00% | 0.00% |
Weiss et al. (2008) | Icelandic patients with schizophrenia, bipolar disorder, ADHD, panic disorder, anxiety, depression, addiction, or dyslexia | 5/5019 | 0.10% | 0.10% | 2/5019 | 0.04% | 0.04% |
Children with mental retardation, developmental delay, or ASD | 5/512e | 0.98% | 0.98% | 4/512 | 0.78% | 0.78% | |
Walsh et al. (2008) | Patients with childhood-onset schizophrenia and IQ ≥70. | 0/83 | 0.00% | 0.00% | 2/83 | 2.41% | 2.41% |
Bijlsma et al. (2009) | Patients with MR/MCA | 14/4284 | 0.33% | 0.33% | Â | Â | Â |
Controlsf | |||||||
This study; Itsara et al. (2009) | 936 middle-aged Americans, 671 NINDS samples, 886 HGDP samples | 0/2393 | 0.00% | 0.00% | 1/2393 | 0.04% | 0.04% |
Sebat et al. (2007)a | Unaffected siblings of individuals with ASD | 0/76 | 0.00% | 0.00% | 0/76 | 0.00% | 0.00% |
99 families without autism | 0/120 | 0.00% | Â | 0/120 | 0.00% | Â | |
Kumar et al. (2008) | NIMH controls | 0/837 | 0.00% | 0.00% | 2/837 | 0.24% | 0.24% |
Weiss et al. (2008) | Parents from multiplex autism families | 0/1420 | 0.00% | 0.02% | 2/1420 | 0.14% | 0.03% |
1087 individuals with bipolar disorder +1727 NIMH controls | 3/2814 | 0.11% | Â | 0/2814 | 0.00% | Â | |
Children's Hospital patients without developmental delay, mental retardation, or ASD | 0/434 | 0.00% | Â | 0/434 | 0.00% | Â | |
Unscreened Icelandic individuals | 2/18834 | 0.01% | Â | 5/18834 | 0.03% | Â | |
Christian et al. (2008)c | NIMH controls | 0/372 | 0.00% | 0.00% | Â | Â | Â |
German blood donors & Canadians >age 60 in coronary artery disease study | 0/2387 | 0.00% | 0.00% | 0/2387 | 0.00% | 0.00% | |
Walsh et al. (2008) | Non-transmitted chromosomes of parents of sample of children with childhood-onset schizophrenia | 0/77 | 0.00% | 0.00% | 0/77 | 0.00% | 0.00% |
Glessner et al. (2009)d, g | Well, ASD-free, Caucasian children | 4/2519 | 0.16% | 0.16% | 4/2519 | 0.16% | 0.16% |